Wenjing Tao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Wenjing Tao has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
- Bingliang Fang
Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
16 shared publications - Carrie Li
Department of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
16 shared publications David Santos
16 shared publications- Hui Guo
Institution of Organ Transplantation, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China
16 shared publications - Jack P. Wang
Forest Biotechnology Group, Department of Forestry and Environmental Resources, North Carolina State University, Raleigh, NC, United States
16 shared publications - Jacqueline Wang
Faculty of Law, University of Macau, Macau S. A. R, China
16 shared publications
Latest Publications
- Open Access
- 28 September 2025
- Published by MDPI AG in Antioxidants
- Vol. 14 (10) , 1186
Protective Effects of Magnolol, Rutin, and Gallic Acid in Broilers Challenged with Dietary Oxidized Soybean Oil
This study evaluated the protective effects of magnolol, rutin, and gallic acid in broilers fed oxidized soybean oil. Four hundred seven-day-old male Arbor Acre broilers were randomly assigned to five treatments with eight replicates each: CON (4% fresh oil), OOC (4% oxidized oil), and OOC supplemented with 200 mg/kg of magnolol (MAG), rutin (RUT), or gallic acid (GAA). OOC significantly reduced 42-day body weight (BW), average daily gain (ADG), and average daily feed intake (ADFI), reduced serum antioxidant enzyme activities (T-SOD, GSH-Px) and elevated malondialdehyde and triglyceride levels. It also upregulated hepatic lipogenic (FASN, ACACA, SREBP-1) and inflammation (NF-κB1/2) genes, damaged intestinal morphology, reduced cecal Erysipelatoclostridium and Shuttleworthia abundances, and elevated oxidized lipids (9,10-DiHOME and prostaglandin G2) in breast muscle. All three polyphenols increased ADFI (22–42 d), ileal villus height and ZO-1 expression, while reducing serum triglycerides, ileal MDA, and hepatic NF-κB2 expression. Both magnolol and rutin further enhanced BW (42 d) and ADG (7–42 d), decreased ACACA expression, and elevated cecal Lachnoclostridium abundance. Additionally, magnolol significantly decreased the contents of 9,10-DiHOME and malondialdehyde, while rutin reduced prostaglandin G2 levels in the breast muscle. In conclusion, polyphenol supplementation alleviated oxidized oil-induced adverse effects, with magnolol and rutin being more effective.
- 28 September 2025
- Published by MDPI AG in Antioxidants
- Vol. 14 (10) , 1186
Open AccessProtective Effects of Magnolol, Rutin, and Gallic Acid in Broilers Challenged with Dietary Oxidized Soybean Oil
This study evaluated the protective effects of magnolol, rutin, and gallic acid in broilers fed oxidized soybean oil. Four hundred seven-day-old male Arbor Acre broilers were randomly assigned to five treatments with eight replicates each: CON (4% fresh oil), OOC (4% oxidized oil), and OOC supplemented with 200 mg/kg of magnolol (MAG), rutin (RUT), or gallic acid (GAA). OOC significantly reduced 42-day body weight (BW), average daily gain (ADG), and average daily feed intake (ADFI), reduced serum antioxidant enzyme activities (T-SOD, GSH-Px) and elevated malondialdehyde and triglyceride levels. It also upregulated hepatic lipogenic (FASN, ACACA, SREBP-1) and inflammation (NF-κB1/2) genes, damaged intestinal morphology, reduced cecal Erysipelatoclostridium and Shuttleworthia abundances, and elevated oxidized lipids (9,10-DiHOME and prostaglandin G2) in breast muscle. All three polyphenols increased ADFI (22–42 d), ileal villus height and ZO-1 expression, while reducing serum triglycerides, ileal MDA, and hepatic NF-κB2 expression. Both magnolol and rutin further enhanced BW (42 d) and ADG (7–42 d), decreased ACACA expression, and elevated cecal Lachnoclostridium abundance. Additionally, magnolol significantly decreased the contents of 9,10-DiHOME and malondialdehyde, while rutin reduced prostaglandin G2 levels in the breast muscle. In conclusion, polyphenol supplementation alleviated oxidized oil-induced adverse effects, with magnolol and rutin being more effective.
- Open Access
- 1 February 2024
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 46 (2) , 1219-1236
Gut–Liver Axis as a Therapeutic Target for Drug-Induced Liver Injury
Drug-induced liver injury (DILI) is a liver disease that remains difficult to predict and diagnose, and the underlying mechanisms are yet to be fully clarified. The gut–liver axis refers to the reciprocal interactions between the gut and the liver, and its homeostasis plays a prominent role in maintaining liver health. It has been recently reported that patients and animals with DILI have a disrupted gut–liver axis, involving altered gut microbiota composition, increased intestinal permeability and lipopolysaccharide translocation, decreased short-chain fatty acids production, and impaired bile acid metabolism homeostasis. The present review will summarize the evidence from both clinical and preclinical studies about the role of the gut–liver axis in the pathogenesis of DILI. Moreover, we will focus attention on the potential therapeutic strategies for DILI based on improving gut–liver axis function, including herbs and phytochemicals, probiotics, fecal microbial transplantation, postbiotics, bile acids, and Farnesoid X receptor agonists.
- 1 February 2024
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 46 (2) , 1219-1236
Open AccessGut–Liver Axis as a Therapeutic Target for Drug-Induced Liver Injury
Drug-induced liver injury (DILI) is a liver disease that remains difficult to predict and diagnose, and the underlying mechanisms are yet to be fully clarified. The gut–liver axis refers to the reciprocal interactions between the gut and the liver, and its homeostasis plays a prominent role in maintaining liver health. It has been recently reported that patients and animals with DILI have a disrupted gut–liver axis, involving altered gut microbiota composition, increased intestinal permeability and lipopolysaccharide translocation, decreased short-chain fatty acids production, and impaired bile acid metabolism homeostasis. The present review will summarize the evidence from both clinical and preclinical studies about the role of the gut–liver axis in the pathogenesis of DILI. Moreover, we will focus attention on the potential therapeutic strategies for DILI based on improving gut–liver axis function, including herbs and phytochemicals, probiotics, fecal microbial transplantation, postbiotics, bile acids, and Farnesoid X receptor agonists.
- Open Access
- 27 June 2023
- Published by MDPI AG in Metabolites
- Vol. 13 (7) , 797
Maternal Magnolol Supplementation during Pregnancy and Lactation Promotes Antioxidant Capacity, Improves Gut Health, and Alters Gut Microbiota and Metabolites of Weanling Piglets
Maternal nutrition exerts a profound effect on the postnatal performance of offspring, especially during the weaning period. The multifunctional bioactive component magnolol (MAG) has shown promise as a dietary supplement. This study aimed to explore the effects of maternal MAG supplementation on the antioxidant capacity, gut health, gut microbiome, and metabolome composition of weanling piglets. Fifty pregnant sows were randomly divided into two equally sized groups, the control group and the group supplemented with 100 g/t MAG during the gestation and lactation periods, and 7 days postweaning, the pups were euthanized. The microbiome and metabolome features of weanling piglet colons were compared. Our results revealed that maternal MAG supplementation modified the serum redox status of weanling piglets by decreasing malondialdehyde concentration and increasing superoxide dismutase activity and total antioxidant capacity. Moreover, the decreased indicators of diarrhea were accompanied by improved gut barrier function, in which serum diamine oxidase concentration was decreased, and expressions of zona occludens-1, claudin-1, and intestinal alkaline phosphatase were increased in the colon of weanling piglets from sows supplemented with MAG. Further analysis of the gut microbiota indicated that maternal MAG supplementation significantly increased the relative abundance of beneficial bacteria in the colon of weanling piglets, including Faecalibacterium prausnitzii and Oscillospira. Metabolome analysis identified 540 differential metabolites in the colon of piglets from MAG-fed dams, of which glycerophospholipid classes were highly correlated with progeny gut health and key beneficial bacteria. Our findings indicated that maternal MAG supplementation can improve the oxidative status and gut health of weanling piglets, possibly due to alterations in the gut microbiota and metabolites.
- 27 June 2023
- Published by MDPI AG in Metabolites
- Vol. 13 (7) , 797
Open AccessMaternal Magnolol Supplementation during Pregnancy and Lactation Promotes Antioxidant Capacity, Improves Gut Health, and Alters Gut Microbiota and Metabolites of Weanling Piglets
Maternal nutrition exerts a profound effect on the postnatal performance of offspring, especially during the weaning period. The multifunctional bioactive component magnolol (MAG) has shown promise as a dietary supplement. This study aimed to explore the effects of maternal MAG supplementation on the antioxidant capacity, gut health, gut microbiome, and metabolome composition of weanling piglets. Fifty pregnant sows were randomly divided into two equally sized groups, the control group and the group supplemented with 100 g/t MAG during the gestation and lactation periods, and 7 days postweaning, the pups were euthanized. The microbiome and metabolome features of weanling piglet colons were compared. Our results revealed that maternal MAG supplementation modified the serum redox status of weanling piglets by decreasing malondialdehyde concentration and increasing superoxide dismutase activity and total antioxidant capacity. Moreover, the decreased indicators of diarrhea were accompanied by improved gut barrier function, in which serum diamine oxidase concentration was decreased, and expressions of zona occludens-1, claudin-1, and intestinal alkaline phosphatase were increased in the colon of weanling piglets from sows supplemented with MAG. Further analysis of the gut microbiota indicated that maternal MAG supplementation significantly increased the relative abundance of beneficial bacteria in the colon of weanling piglets, including Faecalibacterium prausnitzii and Oscillospira. Metabolome analysis identified 540 differential metabolites in the colon of piglets from MAG-fed dams, of which glycerophospholipid classes were highly correlated with progeny gut health and key beneficial bacteria. Our findings indicated that maternal MAG supplementation can improve the oxidative status and gut health of weanling piglets, possibly due to alterations in the gut microbiota and metabolites.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3. Treatment profiling of PDX models from B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy
Freshly isolated lymphoma cells from PT2-BL-G6 and G7 PDXs. Cell viability was tested by CellTiter-Glo luminescent cell viability assay after 48-hour incubation with the indicated drug treatment. The in vitro drug and dose information for IBN and ABT-199 are listed in Supplementary Table S1. IBN, ibrutinib; PT, patient; BL, Burkitt's lymphoma.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3. Treatment profiling of PDX models from B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy
Freshly isolated lymphoma cells from PT2-BL-G6 and G7 PDXs. Cell viability was tested by CellTiter-Glo luminescent cell viability assay after 48-hour incubation with the indicated drug treatment. The in vitro drug and dose information for IBN and ABT-199 are listed in Supplementary Table S1. IBN, ibrutinib; PT, patient; BL, Burkitt's lymphoma.